PRIMARY STUDY

Pharmacological inhibition of the primary endocannabinoid producing enzyme, DGL-α, induces autism spectrum disorder-like and co-morbid phenotypes in adult C57BL/J mice

Key Findings:  Data suggests that pharmacological inhibition of DAGL-alpha prouced a number of behavioral domains deficits associated with autism.